| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Aidan Matthew Collins last filed a Form 4 in February 2016, as Director at SMLR. Aidan Matthew Collins's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,100 shares of SMLR. Net of sales, the SMLR filings show accumulation of 1,000 shares.
Aidan Matthew Collins has 5 Form 4 filings on record from July 2015 to February 2016, all as Director at Semler Scientific (SMLR), 2015–2016.
The 5 reported transactions were 4 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $3K and no sales.
The only open-market purchase was 1,000 shares of SMLR at an average $3.38 on November 4, 2015, about $3K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2015 | SMLR Semler Scientific, Inc. | Director | Buy | 1,000 | $3.38 | $3,384.00 | +1,000% |